Financhill
Back

Generation Bio Quote, Financials, Valuation and Earnings

Generation Bio Price Quote

$5.07
+0.01 (+5.63%)
(Updated: September 2, 2023 at 6:12 AM ET)

Generation Bio Key Stats

Sell
46
Generation Bio (GBIO) is a Sell

Day range:
$4.81 - $5.10
52-week range:
$3.15 - $7.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.31%

Volume:
81.8K
Avg. volume:
97.7K
1-year change:
-5.24%
Market cap:
$333.6M
Revenue:
$0
EPS:
$-2.08

How Much Does Generation Bio Make?

Data Unavailable

Is Generation Bio Growing As A Company?

Data Unavailable

Generation Bio Stock Price Performance

  • Did Generation Bio Stock Go Up Last Month?
    Generation Bio share price went up by 6.75% last month
  • Did GBIO's Share Price Rise Over The Last Year?
    GBIO share price fell by -5.24% over the past 1 year

What Is Generation Bio 52-Week High & Low?

Generation Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Generation Bio?

  • How Much Debt Does Generation Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Generation Bio Have?
    Cash and short term investments quarterly total is $314.1M
  • What Is Generation Bio’s Book Value Per Share?
    Book value per share is 3.87

Is Generation Bio Cash Flow Positive?

  • What Is GBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$46.4M
  • What Is Generation Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $45.3M
  • What Is Generation Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.2M

Generation Bio Return On Invested Capital

Data Unavailable

Generation Bio Earnings Date & Stock Price

Generation Bio Competitors

  • Who Are Generation Bio's Competitors?
    Below is a list of companies who compete with Generation Bio or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Annexon Inc (ANNX)
    • CEL-SCI Corp (CVM)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • MeiraGTx Holdings PLC (MGTX)

Generation Bio Dividend Yield

Data Unavailable

Generation Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.48%
Revenue: 0% -70.26%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.85
Upside from Last Price: 114.48%

Major Shareholders

  • How many GBIO shares are owned by institutional investors?
    81.4M GBIO shares are owned by institutional investors
  • How many GBIO shares are owned by insiders?
    2.9M GBIO shares are owned by insiders